We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Mini Access System Supports Precise Needle Placement

By HospiMedica International staff writers
Posted on 16 Apr 2012
A sextant-like device for central venous catheter (CVC) placement provides a depth scale to adjust positioning, and fits standard ultrasound (US) transducers for observing needle bearing.

The Euclid Tier 1 Mini Access System is designed to access and/or place a guidewire into a blood vessel located 5-60 mm below the skin surface. More...
The system is portable, hand operated, and used in conjunction with commercially available US imaging systems. When coupled, the clinician has the ability to accurately locate, determine the depth, and insert a needle and guidewire into the selected vessel; US imaging enables the user to determine whether or not the guidewire is placed correctly within the vessel.

Technology limitations, inadequate procedure training and exposure, and varying patient size and morphology have all been identified as co-contributors to the high CVC placement complication rates. Use of US imaging during such procedures has been shown to reduce complications, but is often cumbersome and generally requires additional assistance. The Euclid Tier 1 Mini Access System, specifically designed to overcome these issues, is a product of Houston Medical Robotics (TX, USA), and has been approved by the US Food and Drug Administration (FDA).

“Although numerous applications have been identified, our initial target for the Euclid Tier 1 Mini Access System is reducing complications associated with central venous catheter placement,” said Jeffery J. Sheldon, chairman and CEO of Houston Medical Robotics. “With over 5 million CVCs placed each year - and published complication rates are as high as 26% - we are poised to make a significant impact on healthcare outcomes.”

CVC’s are generally placed into the larger veins, such as the internal jugular vein, the subclavian vein, the axillary vein, or the femoral vein. It is used to administer medication or fluids, obtain blood tests (specifically mixed venous oxygen saturation), and directly obtain cardiovascular measurements such as the central venous pressure (CVP). Other, long-term indications include dialysis, administration of antibiotics, parenteral nutrition (especially in the chronically ill), and chemotherapy. Complications include pneumothorax, central-line associated bloodstream infections (CLABSIs), thrombosis, and hemorrhage.

Related Links:

Houston Medical Robotics



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Portable Jaundice Management Device
Nymphaea
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.